📊 NTRBW Key Takeaways
Is NTRBW a Good Investment? Thesis Analysis
NutriBand Inc. is a fundamentally distressed company burning cash at an unsustainable rate with minimal revenue generation. Despite holding $5.3M in cash, operating losses of $7.3M per period combined with negative operating cash flow of $4.4M indicate the company is rapidly consuming its liquidity cushion with no clear path to profitability.
Why Buy NTRBW? Key Strengths
- Strong liquidity position with $5.3M cash representing 63% of total assets
- Minimal debt burden with only $1.8K long-term debt and 0.00x debt-to-equity ratio
- Low current liabilities relative to liquid assets providing short-term solvency
NTRBW Investment Risks to Consider
- Severe operating losses of $7.3M against $1.6M revenue, indicating fundamental business model failure
- Negative operating cash flow of $4.4M per period means company will deplete cash reserves in approximately 1.2 periods at current burn rate
- Revenue stagnation with 0.0% YoY growth while operating expenses remain massive, showing no operational leverage or path to scaling
- Negative ROE of -96.2% and ROA of -86.3% demonstrate value destruction across all invested capital
- Operating margin of -446% and net margin of -443.9% indicate the company loses $4.46 for every dollar of revenue
Key Metrics to Watch
- Quarterly cash position and runway remaining at current burn rate
- Revenue trends and new product launch success in orthopedic appliances sector
- Operating expense reduction initiatives and path to operating cash flow positivity
NTRBW Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 7.53x current ratio provides a solid financial cushion.
NTRBW Profitability Ratios
NTRBW vs Default Sector
How NutriBand Inc. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is NTRBW Overvalued or Undervalued?
Based on fundamental analysis, NutriBand Inc. has mixed fundamental signals relative to the Default sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
NTRBW Balance Sheet & Liquidity
NTRBW 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: NutriBand Inc.'s revenue has grown significantly by 81% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.69 indicates the company is currently unprofitable.
NTRBW Growth Metrics (YoY)
NTRBW Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $346.1K | -$1.4M | $-0.12 |
| Q2 2026 | $442.8K | -$1.7M | $-0.15 |
| Q1 2026 | $408.5K | -$1.4M | $-0.12 |
| Q3 2025 | $427.8K | -$1.4M | $-0.12 |
| Q1 2025 | $408.5K | -$1.0M | $-0.13 |
| Q3 2024 | $427.8K | -$1.1M | $-0.14 |
| Q2 2024 | $442.8K | -$829.2K | $-0.11 |
| Q2 2023 | $456.1K | -$829.2K | $-0.11 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
NTRBW Capital Allocation
NTRBW SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for NutriBand Inc. (CIK: 0001676047)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NTRBW
What is the AI rating for NTRBW?
NutriBand Inc. (NTRBW) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are NTRBW's key strengths?
Claude: Strong liquidity position with $5.3M cash representing 63% of total assets. Minimal debt burden with only $1.8K long-term debt and 0.00x debt-to-equity ratio.
What are the risks of investing in NTRBW?
Claude: Severe operating losses of $7.3M against $1.6M revenue, indicating fundamental business model failure. Negative operating cash flow of $4.4M per period means company will deplete cash reserves in approximately 1.2 periods at current burn rate.
What is NTRBW's revenue and growth?
NutriBand Inc. reported revenue of $1.6M.
Does NTRBW pay dividends?
NutriBand Inc. does not currently pay dividends.
Where can I find NTRBW SEC filings?
Official SEC filings for NutriBand Inc. (CIK: 0001676047) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NTRBW's EPS?
NutriBand Inc. has a diluted EPS of $-2.54.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is NTRBW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, NutriBand Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is NTRBW stock overvalued or undervalued?
Valuation metrics for NTRBW: ROE of -96.2% (sector avg: 15%), net margin of -443.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy NTRBW stock in 2026?
Our dual AI analysis gives NutriBand Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NTRBW's free cash flow?
NutriBand Inc.'s operating cash flow is $-4.4M, with capital expenditures of $5.3K. FCF margin is -269.5%.
How does NTRBW compare to other Default stocks?
Vs Default sector averages: Net margin -443.9% (avg: 12%), ROE -96.2% (avg: 15%), current ratio 7.53 (avg: 1.8).